Follow-The-Filings

ALLO Allogene Therapeutics

Allogene Therapeutics earnings company data as of 5:18 AM ET 9/17

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02
8-K 2.02,9.01
10-Q
424B5
8-K 5.07,8.01
8-K 5.02
DEFA14A
DEFA14A
8-K 1.01,1.02,2.02,9.01
10-Q
DEFA14A
424B5
8-K 8.01,9.01
8-K 8.01
8-K 8.01
424B5
8-K 2.02,9.01
10-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Aug 21, 2026
4 Period Jul 1, 2026
4 Period Jun 18, 2026 · 3 forms

17 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice